Belatacept conversion in African American kidney transplant recipients with severe renal dysfunction

OBJECTIVES: Conversion from calcineurin inhibitor–based maintenance immunosuppression to belatacept in kidney transplant recipients has been demonstrated to improve renal function while maintaining efficacy against rejection. However, conversion studies to date have excluded patients with an estimat...

Descripción completa

Detalles Bibliográficos
Autores principales: Snyder, Heather S, Duhart, Benjamin T, Krauss, Amy G, Rao, Vinaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098796/
https://www.ncbi.nlm.nih.gov/pubmed/27847589
http://dx.doi.org/10.1177/2050313X16674865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098796/
https://www.ncbi.nlm.nih.gov/pubmed/27847589
http://dx.doi.org/10.1177/2050313X16674865

Ejemplares similares